Featured Stem Cell Topics
Latest Articles
Gamida Cell’s Omisirge for SAA gets OK on limited data; more low-data FDA approvals likely to comeThe FDA just announced it approved the cell therapy Omisirge from Gamida Cell for severe aplastic anemia (SAA). This is the first cell therapy approved for SAA. SAA is a rare, life-threatening blood disorder. It is often treated with hematopoietic stem cell transplants or immunosuppression. There’s a major autoimmune component…
Weekly reads: Sam Altman Retro Bio anti-aging, skin organoids, more FDA turmoil
It seems like some multibillionaires either want to live forever or make more money by investing in longevity firms, or …
Could Capricor’s report of strong data on deramiocel for Duchenne spark FDA approval?
The cell therapy biotech Capricor just released new Phase 3 data from its Duchenne Muscular Dystrophy (DMD) program The firm …
Weekly reads: cartilage regeneration, ferroptosis, Aspen Neuroscience raises $115M, more on rare diseases
Cartilage regeneration has been a holy grail for the stem cell field for decades. It has mostly been just out …
Nucleus Genomics faces criticism as it and other firms promise embryo optimization despite unresolved scientific, ethical questions
A new wave of startups like Nucleus Genomics is promising genetically ‘optimized’ future children. However, the science and ethics remain …
Visit Our Facebook Page
Visit our Stem Cell Channel on YouTube
Subscribe to Our Newsletter
Dr. Knoepfler’s TED talk
